Cigna Health Expected to Post Higher 4Q Profit, Revenue -- Earnings Preview

Dow Jones
Feb 05

By Connor Hart

 

Cigna Group is scheduled to report fourth-quarter results before the market opens Thursday. Here is what you need to know.

NET INCOME: The healthcare company is projected to post a profit of $1.74 billion, up from $1.42 billion a year earlier, according to analysts polled by FactSet.

ADJUSTED EARNINGS: Stripping out one-time items, earnings are expected to come in at $7.88 a share. That compares with adjusted earnings of $6.64 a share a year ago.

REVENUE: Quarterly revenue is forecast to be $70.31 billion, up from the $65.68 billion it notched last year.

Shares have climbed 7.1% over the past three months and were recently trading hands at $275.54.

WHAT TO WATCH

--While it has since pared back some of the loss, Cigna's stock dropped last quarter after the company warned the profits for its pharmacy-benefits business would likely be squeezed in 2026. The company attributed the pressure largely to renegotiated contracts with three major clients and costs associated with adopting an ambitious new payment model. Investors will be looking to see if these pressures have started to weigh on the unit's bottom line.

--The Trump administration last month proposed roughly flat rates for Medicare insurers next year, an update that fell well short of Wall Street expectations and triggered a brief selloff among healthcare stocks. The Medicare agency is also proposing to eliminate a lucrative industry billing practice that has raised concerns with government watchdogs. Investors will be eager to see if the company addresses these proposals, and the impact they could have on business.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

February 04, 2026 13:25 ET (18:25 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10